A wireless sensor small enough to be implanted in the blood vessels of the human brain could help clinicians evaluate the healing of aneurysms — bulges that can cause death or serious injury if they burst. The stretchable sensor, which operates without batteries, would be wrapped around stents or diverters implanted to control blood flow in vessels affected by the aneurysms.
Jada Lucas, a 22-year-old bone marrow recipient from Birmingham, met the bone marrow donor who helped save her life — Jerome Lewis of Philadelphia, Penn. — at donor registry event at Children's of Alabama.
Parents, siblings and children of people with celiac disease are at high risk of also having the disease, according to a Mayo Clinic study. This study calls for screening of all first-degree relatives of patients — not just those who show symptoms.
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
Research led by Barbara Nikolajczyk, Ph.D., disproved the conventional wisdom that glucose was the primary driver of chronic inflammation in type 2 diabetes. The data might change opinion of tight glycemic control as the optimal strategy for type 2 diabetes management.
The 5E Medical Oncology/Hematology Unit at MedStar Washington Hospital Center has received the prestigious AMSN PRISM Award®, an honor recognizing exceptional nursing practice, leadership, and outcomes in hospital medical-surgical units. The award, which stands for “Premier Recognition In the Specialty of Med-Surg,” is the first of its kind honoring med-surg nursing units in the United States and internationally.
In a study that spanned two and a half decades and looked at data from more than 4,700 participants, Johns Hopkins researchers have added to evidence that abnormal blood pressure in midlife persisting into late life increases the likelihood of developing dementia. Although not designed to show cause and effect, the study suggests that maintaining a healthy blood pressure throughout life may be one way to help decrease one’s risk of losing brain function.
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides a new and unexpected therapeutic target for new drug development.
University of Chicago Medicine oncologist and professor Richard A. Larson, MD, will receive the 2019 Henry M. Stratton Medal from the American Society of Hematology.
Physicians have long suspected that red blood cell transfusions given to premature infants with anemia may put them in danger of developing necrotizing enterocolitis, or NEC, a potentially lethal inflammatory disease of the intestines. However, solid evidence for the connection has been difficult to obtain in part because of the lack of a practical animal model able to accurately represent what physically occurs when a baby gets NEC.
An antibody that blocks the "programmed cell death" pathway may help the immune system fight off sepsis-related fungal infections, according to animal studies reported in SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Brian Walker, Ph.D., with the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) has received a $542,486, three-year grant from the Leukemia & Lymphoma Society to look at changes in the DNA sequence that effects the development and advancement of multiple myeloma, a cancer of plasma cells in the blood.
Samplla™, a family of specimen collection devices which are designed to provide ambient transportation for up to 21 days. Specimens applied to Samplla™ are immediately “dried and stabilized” within a local atmospheric condition using its Samplla Modified Atmosphere Packaging (sMAP), that provides an atmosphere separated from the ambient atmosphere and resistant to gas exchange – the result, stability. Samplla™ S device, the first product of this line of products was perfected to collect, transport and store bodily fluid specimens.
Beckman Coulter’s DxH 520 Hematology Analyzer receives Scientists’ Choice Award and Named Best New Clinical Product
Samplla™, a family of specimen collection devices which are designed to provide ambient transportation for up to 21 days. Specimens applied to Samplla™ are immediately “dried and stabilized” within a local atmospheric condition using its Samplla Modified Atmosphere Packaging (sMAP), that provides an atmosphere separated from the ambient atmosphere and resistant to gas exchange – the result, stability. Samplla™ S device, the first product of this line of products was perfected to collect, transport and store bodily fluid specimens.
Pixcell’s HemoScreen™ is a portable cartridge-based platform. It is fast, simple to use, and a cost-effective means of providing crucial diagnostic information, near patient, where it is needed most.
HemoScreen’s™ Viscoelastic Focusing; A breakthrough in cellular analysis for Hematology and other critical POC assays.
Visit Beckman Coulter at AACC 2019 to experience how automation helps solve the unique challenges of small-, mid- and high-volume laboratories
A blood test to detect the brain changes of early Alzheimer’s disease has moved one step closer to reality. Researchers from Washington University School of Medicine in St. Louis report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain. The findings represent a key step toward a blood test to diagnose people on track to develop the devastating disease before symptoms arise.
More than 1 million sepsis survivors are discharged annually from acute care hospitals in the United States. Although the majority of these patients receive post-acute care (PAC) services, with over a third coming to home health care (HHC), sepsis survivors account for a majority of readmissions nationwide. Effective interventions are needed to decrease these poor outcomes.
Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The 2019 translational hypertension symposium features nationally renowned experts addressing topics related to diagnosing hypertension, more effective and durable blood pressure control and cardiovascular disease risk reduction for all communities.
Researchers from Case Western Reserve University School of Medicine have developed a new combination treatment regimen that enhances the immune system’s ability to kill leukemias that do not respond to standard treatments. The regimen includes a therapeutic antibody designed to draw natural killer immune cells to cancer cells.
High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians trying to make their best guess. That’s until researchers released results of a pioneering study that used a series of personalized trials to identify a preferred therapy for kids – the first step in tackling the problem.
New anticoagulant medications have expanded options to prevent venous thromboembolism (VTE) and treat patients at risk for excessive blood clots. Although certain therapies such as heparin and warfarin are time-tested and generally well understood by providers, newer anticoagulants provide both patients and providers with attractive options.
A first-in-class drug recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) for adult patients with heavily pretreated multiple myeloma has been the subject of study at Moffitt Cancer Center for years. Now, selinexor (XPOVIO™, Karyopharm Therapeutics) used in combination with the corticosteroid dexamethasone will offer another option for patients with multiple myeloma who have exhausted the most common therapies for the disease.
High blood sugar may increase the risk of pancreatic cancer, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The Coriell Institute for Medical Research is now participating in a prestigious SU2C Catalyst® grant from Stand Up To Cancer for the study of epigenetic therapy in treating urothelial cancer, a common form of cancer typically found in the bladder. Part of the project grant was moved to Coriell following its hiring of Jean-Pierre Issa, MD, as its new President and Chief Executive Officer.
Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status.
New research in JNCCN from the Hutchinson Institute for Cancer Outcomes Research (HICOR) within the Fred Hutch/University of Washington Cancer Consortium—part of the Seattle Cancer Care Alliance—identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
Burst Biologics, a globally recognized institute in pharmaceutical research and tissue bank that services communities across the U.S., has published a research study entitled "Characterization of an umbilical cord blood sourced product suitable for allogeneic applications" in the prestigious peer-reviewed journal, Regenerative Medicine. This study is part of Burst Biologics' ongoing commitment to groundbreaking research.
Blood tests can diagnose disease, determine organ function and help your doctor see how well treatments are working. Here’s why they sometimes require so many samples – and why you can’t eat ahead of time.
More than $2 million in grants recently awarded to a Rutgers Cancer Institute of New Jersey resident researcher will support examination of potential treatment targets for T-cell acute lymphoblastic leukemia (T-ALL).
Dr. Phil Evans was honored with National Breast Cancer Foundation's Lifetime Achievement Award.
80% of the world’s population has limited access to testing laboratories. Part of that problem is being addressed by mobile blood collection services done by independent professionals. For example, in US this blood collection service is being provided by independent mobile phlebotomy organizations.
Hemoglobinopathia are diseases associated with a genetic abnormality of hemoglobin, blood protein used to transport oxygen. Hemoglobin is found basically inside red blood cells (erythrocytes), which gives them their red color.
Researchers have developed a significantly improved delivery mechanism for the CRISPR/Cas9 gene editing method in the liver. The delivery uses biodegradable synthetic lipid nanoparticles that carry the molecular editing tools into cells to precisely alter their genetic code with as much as 90 percent efficiency.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance.
Patients with sickle cell disease experience severe organ damage leading to early death. An international clinical trial funded by the NIH will test whether red cell exchange, which replaces sicked red blood cells with normal ones could prevent or reverse organ damage and prolong life.
Preeclampsia is just as hard to accurately diagnose now as it was 100 years ago, said Baha Sibai, MD, a maternal-fetal medicine specialist with UTHealth. Researchers at McGovern Medical School are looking for ways to change that.
Researchers who analyzed data in the electronic health records of children seen by hematology/oncology specialists at three large medical centers have developed an algorithm to accurately identify appropriate pediatric oncology patients for future clinical studies.
People with chronic diseases like arthritis, diabetes and heart disease may one day forego the daily regimen of pills and, instead, receive a scheduled dosage of medication through a grape-sized implant that is remotely controlled.
Dr. Eugene P. Frenkel, an internationally recognized cancer researcher and admired clinician and educator who pioneered UT Southwestern Medical Center’s Division of Hematology and Oncology, died June 21, 2019. He was 89.
A global study looking at the role that iron plays in 900 diseases has uncovered the impact of both low and high iron counts – and the news is mixed.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.
June 19 is World Sickle Cell Awareness Day. Scientists at Cincinnati Children's have recently made three important steps forward in helping people with sickle cell in the U.S. and in sub-Saharan Africa live longer, better lives.
Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer. The altered cells remain active for years after the treatment, acting as a 'living drug' Only specially-certified trained hospitals can offer CAR T-cell therapy to patients with B-cell acute lymphocytic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).
Top renal experts will discuss current and cutting-edge research on kidney function at the upcoming American Physiological Society (APS)/American Society of Nephrology (ASN) Conference: Control of Renal Function in Health and Disease in Charlottesville, Va.
Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, led an International Myeloma Working Group (IMWG) effort to compile new recommendations for imaging techniques that offer more sensitive and accurate diagnosis and monitoring for patients with multiple myeloma and other plasma-cell disorders.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right